Karel Berka

Scopus Author ID ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 14

Top Venues

Molecular pharmaceutics

Nucleic acids research

Acta crystallographica. Section D, Structural biology

Nature methods

Palacký University, Olomouc

Charles University in Prague (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Palacký University, Olomouc Sep 01 2018

Czechia

Associate Professor :: Department of Physical Chemistry

Palacký University, Olomouc Mar 01 2010 - Aug 31 2018

Czechia

Assistant Professor/Postdoc Fellow :: Department of Physical Chemistry

Institute of Organic Chemistry and Biochemistry Oct 01 2006 - Feb 28 2010

Czechia

graduate student :: Pavel Hobza group

Education History

Charles University in Prague Oct 01 2006 - Feb 28 2010

Czechia

PHD :: Department of Physical and Macromolecular Chemistry, Faculty of Science

Publications

Klára Odehnalová, Martin Balouch, Kateřina Storchmannová, Eliška Petrová, Magdalena Konefał, Aleš Zadražil, Karel Berka, Jiří Brus, František Štěpánek
Liposomal Copermeation Assay Reveals Unexpected Membrane Interactions of Commonly Prescribed Drugs. Molecular pharmaceutics (2024)
Klára Odehnalová, Martin Balouch, Kateřina Storchmannová, Eliška Petrová, Magdalena Konefał, Aleš Zadražil, Karel Berka, Jiří Brus, František Štěpánek
Liposomal Copermeation Assay Reveals Unexpected Membrane Interactions of Commonly Prescribed Drugs. Molecular pharmaceutics 21 (6) (2024)
Klára Odehnalová, Martin Balouch, Kateřina Storchmannová, Eliška Petrová, Magdalena Konefał, Aleš Zadražil, Karel Berka, Jiří Brus, František Štěpánek
Liposomal Copermeation Assay Reveals Unexpected Membrane Interactions of Commonly Prescribed Drugs. Molecular pharmaceutics 21 (6) (2024)
Anna Špačková, Ondřej Vávra, Tomáš Raček, Václav Bazgier, David Sehnal, Jiří Damborský, Radka Svobodová, David Bednář, Karel Berka
ChannelsDB 2.0: a comprehensive database of protein tunnels and pores in AlphaFold era. Nucleic acids research (2023)
Aliaksei Chareshneu, Adam Midlik, Crina-Maria Ionescu, Alexander Rose, Vladimír Horský, Alessio Cantara, Radka Svobodová, Karel Berka, David Sehnal
Mol* Volumes and Segmentations: visualization and interpretation of cell imaging data alongside macromolecular structure data and biological annotations. Nucleic acids research (2023)
Ondřej Schindler, Karel Berka, Alessio Cantara, Aleš Křenek, Dominik Tichý, Tomáš Raček, Radka Svobodová
αCharges: partial atomic charges for AlphaFold structures in high quality. Nucleic acids research (2023)
Martin Balouch, Kateřina Storchmannová, František Štěpánek, Karel Berka
Computational Prodrug Design Methodology for Liposome Formulability Enhancement of Small-Molecule APIs. Molecular pharmaceutics (2023)
Adam Midlik, Ivana Hutařová Vařeková, Jan Hutař, Aliaksei Chareshneu, Karel Berka, Radka Svobodová
OverProt: secondary structure consensus for protein families. Bioinformatics (Oxford, England) 38 (14) (2022)
David Sehnal, Radka Svobodová, Karel Berka, Alexander S Rose, Stephen K Burley, Sameer Velankar, Jaroslav Koča
High-performance macromolecular data delivery and visualization for the web. Corrigendum. Acta crystallographica. Section D, Structural biology 77 (Pt 1) (2021)
David Sehnal, Sebastian Bittrich, Mandar S Deshpande, Radka Svobodová, Karel Berka, Václav Bazgier, Sameer Velankar, Stephen K Burley, Jaroslav Koča, Alexander S Rose
Mol* Viewer: modern web app for 3D visualization and analysis of large biomolecular structures. Nucleic acids research 49 (W1) (2021)
David Sehnal, Radka Svobodová, Karel Berka, Alexander S Rose, Stephen K Burley, Sameer Velankar, Jaroslav Koča
High-performance macromolecular data delivery and visualization for the web. Acta crystallographica. Section D, Structural biology 76 (Pt 12) (2020)
David Sehnal, Mandar S Deshpande, Radka Svobodová Vařeková, Saqib Mir, Karel Berka, Adam Midlik, Lukáš Pravda, Sameer Velankar, Jaroslav Koča
LiteMol suite: interactive web-based visualization of large-scale macromolecular structure data. Nature methods 14 (12) (2019)
Tomáš Gucký, Eva Řezníčková, Tereza Radošová Muchová, Radek Jorda, Zuzana Klejová, Veronika Malínková, Karel Berka, Václav Bazgier, Haresh Ajani, Martin Lepšík, Vladimír Divoký, Vladimir Kryštof
Discovery of N2-(4-Amino-cyclohexyl)-9-cyclopentyl- N6-(4-morpholin-4-ylmethyl-phenyl)- 9H-purine-2,6-diamine as a Potent FLT3 Kinase Inhibitor for Acute Myeloid Leukemia with FLT3 Mutations. Journal of medicinal chemistry 61 (9) (2018)
Petra Čechová, Karel Berka, Martin Kubala
Ion Pathways in the Na+/K+-ATPase. Journal of chemical information and modeling 56 (12) (2016)

Karel Berka.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Karel Berka